Somatic mutations of the ERBB4 kinase domain in human cancers.

作者: Young Hwa Soung , Jong Woo Lee , Su Young Kim , Young Pil Wang , Keon Hyun Jo

DOI: 10.1002/IJC.21507

关键词:

摘要: The EGFR family consists of 4 receptor tyrosine kinases, (ERBB1), ERBB2 (HER2), ERBB3 (HER3) and ERBB4 (HER4). Recent reports revealed that the kinase domains both (ERBB1) gene were somatically mutated in human cancers, raising possibility other ERBB members possess somatic mutations cancers. Here, we performed mutational analysis domain by polymerase chain reaction-single-strand conformation polymorphism assay 595 cancer tissues from stomach, lung, colon breast. We detected 3 180 gastric carcinomas (1.7%), 104 colorectal (2.9%), 5 217 nonsmall cell lung cancers (2.3%) 1 94 breast (1.1%). 12 consisted in-frame duplication mutation 8 missense exons, introns. simultaneously analyzed EGFR, ERBB2, K-RAS, PIK3CA BRAF genes samples with found carcinoma also harbored K-RAS mutation. Our study demonstrated addition to occurs common suggested alterations ERBB4-mediated signaling pathway may contribute development

参考文章(24)
Jim R Woodburn, Susan E Ashton, Simon P Guy, Keith H Gibson, Brenda J Curry, Andrew J Barker, Alan E Wakeling, ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Research. ,vol. 62, pp. 5749- 5754 ,(2002)
Andreas Gschwind, Oliver M. Fischer, Axel Ullrich, The discovery of receptor tyrosine kinases: targets for cancer therapy. Nature Reviews Cancer. ,vol. 4, pp. 361- 370 ,(2004) , 10.1038/NRC1360
Wladimir V. Bogomoletz, Early gastric cancer. The American Journal of Surgical Pathology. ,vol. 8, pp. 381- 391 ,(1984) , 10.1097/00000478-198405000-00007
G Carpenter, ErbB-4: mechanism of action and biology. Experimental Cell Research. ,vol. 284, pp. 66- 77 ,(2003) , 10.1016/S0014-4827(02)00100-3
Ami Citri, Kochupurakkal Bose Skaria, Yosef Yarden, The deaf and the dumb: the biology of ErbB-2 and ErbB-3 Experimental Cell Research. ,vol. 284, pp. 54- 65 ,(2003) , 10.1016/S0014-4827(02)00101-5
Sug Hyung Lee, Jong Woo Lee, Young Hwa Soung, Hong Sug Kim, Won Sang Park, Su Young Kim, Jong Heun Lee, Jik Young Park, Yong Gu Cho, Chang Jae Kim, Suk Woo Nam, Sang Ho Kim, Jung Young Lee, Nam Jin Yoo, BRAF and KRAS mutations in stomach cancer. Oncogene. ,vol. 22, pp. 6942- 6945 ,(2003) , 10.1038/SJ.ONC.1206749
Jong Woo Lee, Young Hwa Soung, Su Young Kim, Hae Woo Lee, Won Sang Park, Suk Woo Nam, Sang Ho Kim, Jung Young Lee, Nam Jin Yoo, Sug Hyung Lee, PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas Oncogene. ,vol. 24, pp. 1477- 1480 ,(2005) , 10.1038/SJ.ONC.1208304
Jong Woo Lee, Young Hwa Soung, Su Young Kim, Won Sang Park, Suk Woo Nam, Jung Young Lee, Nam Jin Yoo, Sug Hyung Lee, Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer. International Journal of Cancer. ,vol. 113, pp. 510- 511 ,(2005) , 10.1002/IJC.20591
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Robert N Jorissen, Francesca Walker, Normand Pouliot, Thomas PJ Garrett, Colin W Ward, Antony W Burgess, Epidermal growth factor receptor: mechanisms of activation and signalling. Experimental Cell Research. ,vol. 284, pp. 31- 53 ,(2003) , 10.1016/S0014-4827(02)00098-8